BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Endo Announces Certain Preliminary Financial Results for Third-Quarter 2017 and Affirms Selected 2017 Financial Guidance

  Endo International today announced certain preliminary results for the quarter ended September 30, 2017 and also affirmed that for the twelve months ending December 31, 2017, the Company expects revenues to be between $3.38B and $3.53B.

  October 30, 2017

   · 

  15 min read
• 

  FDA

  NeoLight Wins FDA Nod for Medical Device Poised to Disrupt Newborn Care Market

  Through its empathy-driven innovation model, NeoLight develops technologies that treat infants with life threatening medical conditions.

  October 30, 2017

   · 

  1 min read
• Business

  GRAMINEX Expands Its Partnership With IDIPharma After Clinical Study Publication.

  IDIPharma and Graminex have agreed to expand clinical research on Graminex Flower Pollen Extract.

  October 30, 2017

   · 

  2 min read
• Business

  Boehringer Ingelheim Expands Collaboration With Sarah Cannon Research Institute to Investigate Novel Immuno-Oncology Combination Therapy

  Boehringer Ingelheim and Sarah Cannon Research Institute today announced an expansion of their strategic partnership which combines Boehringer Ingelheim’s oncology research and Sarah Cannon’s expertise in clinical trial design.

  October 30, 2017

   · 

  5 min read
• Bio NC

  CMP Pharma Announces That CaroSpir, the First and Only FDA-Approved Spironolactone Oral Suspension, is Now Available

  CaroSpir was approved by the FDA on August 4, 2017 and is now available through normal retail distribution.

  October 30, 2017

   · 

  4 min read
• Business

  Pulmatrix Appoints Dr. James Roach as Chief Medical Officer

  Pulmatrix today announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new CMO, effective November 3, 2017.

  October 30, 2017

   · 

  5 min read
• Business

  Cerveau Technologies Announces a Partnership With Landmark Alzheimer’s Disease DIAN-TU Trial

  The trial will include Cerveau’s MK-6240, an investigational imaging biomarker targeting disease progression.

  October 30, 2017

   · 

  3 min read
• Drug Development

  Mateon Therapeutics Announces Updated Data from Fifth Cohort of Phase Ib Study of OXi4503 in Acute Myeloid Leukemia

  Mateon previously reported that two of four patients in this cohort of the study had morphological complete remissions following one cycle of treatment with OXi4503.

  October 30, 2017

   · 

  5 min read
• Policy

  Marrone Bio Innovations Receives EPA Approval for Novel Biofungicide

  Stargus is proven highly effective for controlling downy mildews and white molds.

  October 30, 2017

   · 

  5 min read
• Drug Development

  New Preclinical Data Suggest That Cellectar Biosciences’ PDC Platform Provides Enhanced Outcomes in Combination With External Radiation

  Investigators observed that CLR 127 was taken up and retained in the tumor cells at 6-10 fold higher level than normal tissue and sensitized the tumor cells to external radiation.

  October 30, 2017

   · 

  4 min read